WASHINGTON — The Pentagon formally dropped its COVID-19 vaccination mandate Tuesday, but a new memo signed by Defense Secretary Lloyd Austin also gives commanders some discretion in how or whether Read more
Tag: vaccine
Ocugen stock up 16% premarket after company announced positive results for its COVID vaccine
Ocugen Inc. stock OCGN, +0.78% rallied 16% in premarket trade Monday, after the biopharma company announced positive results in a trial of its COVID vaccine Covaxin. The Phase 2/3 trial Read more
Senate votes to scrap COVID vaccine mandate for military
A bill to rescind the COVID vaccine mandate for members of the U.S. military and to provide nearly $858 billion for national defense passed the Senate on Thursday and is Read more
China sees violent protests against COVID restrictions, and U.S. cases have been rising
Protests in northeastern China against the government’s zero-COVID policy became violent, as seven people were arrested after a clash between residents and police enforcing quarantine restrictions, the Associated Press reported. Read more
Novavax says Phase 3 trial of omicron-targeting COVID vaccine supports its use as a booster
Novavax Inc. NVAX, -1.88% said Tuesday a late-stage trial of its vaccine targeting the COVID variant omicron supports its continued and future use as a booster. The company said the Read more
Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day
First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a “substantially higher” immune response in adults than Read more
Wall Street is being nicer on earnings as vaccine makers, fintech reports near
With a downcast earnings season passing the halfway mark, results from financial-technology and vaccine makers will arrive this week amid questions about consumer spending and demand for COVID-19 drugs. As Read more
GSK respiratory syncytial virus vaccine Phase 3 trial meets primary endpoint
GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine candidate for adults aged over 60 years met its primary endpoint. The U.K.-based maker of Read more
Large number of U.S. COVID deaths could be prevented if patients would take Pfizer’s Paxlovid, White House coordinator warns
A large number of U.S. COVID deaths could be prevented if patients would take Paxlovid, the antiviral developed by Pfizer PFE, -1.79% that helps reduce the risk of hospitalization and Read more
Large number of U.S. COVID deaths could be prevented if patients would take Pfizer’s Paxlovid, White House coordinator warns
A large number of U.S. COVID deaths could be prevented if patients would take Paxlovid, the antiviral developed by Pfizer PFE, -1.62% that helps reduce the risk of hospitalization and Read more